Thus, it is not surprising that key proinflammatory cytokines, including TNF-a, IL-6, CCL2, and CCL5, which are present at high serum concentrations in patients with insulin resistance, are mediators of HSC activation [32, 33]. The gene discussed is CCL2; the disease is Insulin resistance.